Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2010
12/09/2010WO2009149106A3 Microparticles for the treatment of disease
12/09/2010WO2009142525A3 Capsulating system binding to nucleolin
12/09/2010US20100312328 Drug-delivery endovascular stent and method of forming the same
12/09/2010US20100312191 Microneedle Devices and Methods of Manufacture and Use Thereof
12/09/2010US20100311944 Cyclosporine analogue mixtures and their use as immunomodulating agents
12/09/2010US20100311802 Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent
12/09/2010US20100311707 Controlled release delivery system for nasal applications and methods of treatment
12/09/2010US20100311706 Method of treatment of allergic rhinitis
12/09/2010US20100311705 Ophthalmologic irrigation solutions and method
12/09/2010US20100311662 Treatment of Acute Coronary Syndrome with an Exendin
12/09/2010US20100311595 Lipophilic drug delivery vehicle and methods of use thereof
12/09/2010US20100310671 Encapsulated low viscosity hydrophobic liquid actives
12/09/2010US20100310670 Sustained-release microsphere containing short chain deoxyribonucleic acid or short chain ribonucleic acid and method of producing the same
12/09/2010US20100310669 Dispersion of Poloxamer- Protein Particles, Methods of Manufacturing and Uses Thereof
12/09/2010US20100310668 Pharmaceutical compositions comprising n-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene)methyl]-2,4-dimethyl-1h-pyrrole-3-carboxamide
12/09/2010US20100310667 Controlled-release floating pharmaceutical compositions
12/09/2010US20100310666 Delivery of Functional Compounds
12/09/2010US20100310665 Bacteriostatic or bacteriocidal compositions and methods
12/09/2010US20100310664 Compositions and methods for treating insulin resistance and diabetes mellitus
12/09/2010US20100310663 Pharmaceutical compositions comprising nanoparticles and a resuspending material
12/09/2010US20100310662 Oral Drug Delivery System for Azole, Moxifloxacin and Rifampicin
12/09/2010US20100310661 Oral formulations for picoplatin
12/09/2010US20100310660 Dry powder microparticles for pulmonary delivery
12/09/2010US20100310659 Compositions and Uses Thereof
12/09/2010US20100310658 Electroprocessed Fibrin-Based Matrices and Tissues
12/09/2010US20100310657 Pharmaceutical composition for treatment and prevention of kidney diseases
12/09/2010US20100310656 Immunotherapy and prevention of autoimmune hepatitis
12/09/2010US20100310655 Crystal modification A of 1-(2,6-difluorobenzyl)-1 H-1,2,3-triazole-4-carboxamide and dosage forms and formulations thereof
12/09/2010US20100310654 Homeopathic remedies for use before and after aesthetic injectable and surgical procedures to minimize swelling and bruising
12/09/2010US20100310653 Use of an extract made of leaves of ginkgo biloba
12/09/2010US20100310652 Coated extended release pharmaceutical compositions of levetiracetam
12/09/2010US20100310651 Solid pharmaceutical compositions and processes for their production
12/09/2010US20100310650 Pharmaceutical composition for the oral administration of omega polyenoic fatty acids and one or more active principles incompatible therewith, and a process for its preparation
12/09/2010US20100310649 Solid lipid microcapsules containing growth hormone inner core microparticles
12/09/2010US20100310648 Pharmaceutical dosage form for oral administration of a bcl 2 family inhibitor
12/09/2010US20100310647 Enzymatic Synthesis of Polymers
12/09/2010US20100310646 Selective exosite inhibition of papp-a activity against igfbp-4
12/09/2010US20100310645 Methods for inhibiting tumor cell proliferation
12/09/2010US20100310644 Anti-dandruff compositions containing peptides
12/09/2010US20100310643 Cd133 epitopes
12/09/2010US20100310642 Topical Drug Delivery Systems for Ophthalmic Use
12/09/2010US20100310641 Therapeutic approaches for treating cmt and related disorders
12/09/2010US20100310640 Hla-dr binding peptides and their uses
12/09/2010US20100310639 Immuno-modulatory composition
12/09/2010US20100310638 Liposomes comprising duramycin and anti-viral agents
12/09/2010US20100310637 Composition and method for the treatment or prevention of glaucoma and ocular hypertension
12/09/2010US20100310636 Stearically stabilized unilamilar vesicles, process for preparation thereof and use thereof
12/09/2010US20100310635 Compositions and Methods for Regulating T-Cell Activity
12/09/2010US20100310634 Transdermal therapeutic system having urea components
12/09/2010US20100310632 Micro-membrane implant with cusped opening
12/09/2010US20100310631 Filament based on hyaluronic acid in the form of free acid and method for obtaining it
12/09/2010US20100310630 Coated surface for cell culture
12/09/2010US20100310621 Controlled Iodine Release Particle Micro-Biocide
12/09/2010US20100310619 Sonny's Miracle
12/09/2010US20100310613 Drug delivery system
12/09/2010US20100310612 Medicament for the Treatment of Cancer of the Pancreas
12/09/2010US20100310611 Parenteral and oral formulations of benzimidazoles
12/09/2010US20100310610 Compositions and methods for controlling drug loss and delivery in transdermal drug delivery systems
12/09/2010US20100310609 Compositions and methods for treatment of neurodegenerative diseases
12/09/2010US20100310608 Sequestering subunit and related compositions and methods
12/09/2010US20100310607 Pharmaceutical formulations
12/09/2010US20100310477 Pharmaceutical compositions based on anticholingerics and additional active ingredients
12/09/2010US20100310476 Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
12/09/2010US20100310475 Biocide Capsules, Preparation Comprising them and Sanitary Pad Comprising the Preparation
12/09/2010US20100310465 Nano-devices having releasable seals for controlled release of molecules
12/09/2010US20100310464 Antibodies
12/09/2010US20100310455 Heterocyclic Ligands for Integrin Imaging and Therapy
12/09/2010DE202009018024U1 Quetiapin-Zusammensetzung Quetiapine composition
12/09/2010DE102009013469A1 Zubereitung zur äußerlichen Anwendung Preparation for external use
12/09/2010DE10200657B4 2:1-Komplex aus β- oder γ-Cyclodextrin und α-Tocopherol 2: 1 complex of β- or γ-cyclodextrin and α-tocopherol
12/09/2010DE102005011367B4 Verfahren zur Herstellung von Cellulosesulfat mit verbesserten Eigenschaften A process for the production of cellulose sulfate with improved characteristics
12/09/2010CA2841499A1 Compositions and methods for preventing sternal wound infections
12/09/2010CA2764517A1 Dosage form
12/09/2010CA2764482A1 Compositions and methods for delivery of materials
12/09/2010CA2764477A1 Ophthalmic formulations, methods of manufacture, and methods of using same
12/09/2010CA2764424A1 Vaccine for mycoplasma infection
12/09/2010CA2764329A1 Omega-3 oil containing ophthalmic emulsions
12/09/2010CA2764327A1 Ophthalmic oil-in-water emulsions containing cyclosporine or a polyphenol
12/09/2010CA2764326A1 Therapeutic ophthalmic emulsions
12/09/2010CA2764227A1 Formulations for the treatment of deep tissue pain
12/09/2010CA2764204A1 Spray-dried dye compositions, process for the production and use thereof
12/09/2010CA2764134A1 Compositions and methods for preventing sternal wound infections
12/09/2010CA2764051A1 Stabilised composition comprising at least one adrenergic compound
12/09/2010CA2764050A1 Stabilised composition comprising at least one adrenergic compound
12/09/2010CA2763989A1 Immuno-compatible hydrogel system
12/09/2010CA2763458A1 Topical micro-emulsions for the treatment of rheumatic disorders
12/09/2010CA2763040A1 Methods and compositions for the treatment of cancer
12/09/2010CA2762918A1 Preparation method of drug loaded emulsion
12/09/2010CA2758812A1 Method to stabilize a dietary supplement comprising glucosamine
12/08/2010EP2258742A1 Polyhydroxyalkanoate compositons having controlled degradation rates
12/08/2010EP2258722A2 Antibodies to fibroblast growth factor-like (FGF-like) polypeptides
12/08/2010EP2258447A2 Essential n-3 fatty acids in cardiac insufficiency and heart failure therapy
12/08/2010EP2258441A2 Devices for transcutaneous delivery of vaccines and transdermal delivery of drugs
12/08/2010EP2258440A2 Implantable devices for delivering drugs and other substances to treat sinusitis and other disorders
12/08/2010EP2258407A2 Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
12/08/2010EP2258402A2 Dried composition
12/08/2010EP2258396A1 Transdermally absorbable preparation
12/08/2010EP2258395A1 Therapeutic agent for fibroid lung
12/08/2010EP2258394A1 Oral dosage form comprising a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient
12/08/2010EP2258390A1 Improved bacterial outer membrane vesicles
1 ... 798 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 ... 2991